Candel Therapeutics (CADL) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free CADL Stock Alerts $5.54 +0.37 (+7.16%) (As of 04/22/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCandel Therapeutics: CAN-2409 May Go Beyond Scope Of Targeting Pancreatic Cancerseekingalpha.com - April 15 at 7:27 PMShort Interest in Candel Therapeutics, Inc. (NASDAQ:CADL) Grows By 9.2%marketbeat.com - April 15 at 6:28 PMCandel Therapeutics' CAN-2409 For Pancreatic Cancer Gets FDA Orphan Drug Designation; Stock Upmarkets.businessinsider.com - April 11 at 1:53 PMWhy Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionmarkets.businessinsider.com - April 11 at 1:53 PMCandel Therapeutics Shares Leap Premarket on FDA Orphan-Drug Designationmarketwatch.com - April 11 at 1:53 PMCandel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancerglobenewswire.com - April 11 at 9:00 AMCandel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumorsglobenewswire.com - April 9 at 8:00 AMRetail investors invested in Candel Therapeutics, Inc. (NASDAQ:CADL) up 320% last week, insiders too were rewardedfinance.yahoo.com - April 6 at 12:23 PMWhat's Going On With Candel Therapeutics Stock On Friday?benzinga.com - April 5 at 1:43 PMCandel Therapeutics stock jumps as pancreatic cancer treatment shows promisemsn.com - April 5 at 1:43 PMmarketbeat.com - April 5 at 12:19 PMmarketbeat.com - April 5 at 12:03 PMmarketbeat.com - April 5 at 10:31 AMmarketbeat.com - April 5 at 10:12 AMmarketbeat.com - April 5 at 9:41 AMUnusually High Volume Points to Upside in These Stocksmarketbeat.com - April 5 at 7:46 AMUnusually High Volume Points to Upside in These Stocksmarketbeat.com - April 5 at 7:45 AMWhy Allurion Technologies Stock Is Racing Highermsn.com - April 4 at 5:40 PMAfter-hours movers: SoFi Technologies, GameStop, and moreinvesting.com - April 4 at 5:40 PMmarketbeat.com - April 4 at 3:22 PMCandel Therapeutics Shares Hit 52-Week High After Positive Trial Datamarketwatch.com - April 4 at 12:40 PMCandel's CAN-2409 Shows Positive Trial Results In Non-Metastatic Pancreatic Cancer; Stock Upmarkets.businessinsider.com - April 4 at 12:40 PMAfter Brain Cancer Data, Candel Therapeutics' Shares Good News From Pancreatic Cancer Studyfinance.yahoo.com - April 4 at 12:40 PMCandel Therapeutics Announces Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancerglobenewswire.com - April 4 at 8:00 AMMicro-Cap Cancer Focused Candel Therapeutics Highlights Encouraging Data From Brain Tumor Immunotherapymsn.com - April 1 at 4:24 PMCandel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Gliomaglobenewswire.com - March 28 at 4:05 PMCADL Stock Earnings: Candel Therapeutics Misses EPS for Q4 2023investorplace.com - March 28 at 3:10 PMRecap: Candel Therapeutics Q4 Earningsbenzinga.com - March 28 at 10:43 AMCandel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlightsglobenewswire.com - March 28 at 8:05 AMCandel Therapeutics Announces an Upcoming Presentation at the AACR Annual Meeting Unveiling New Cancer Immunotherapy Candidateglobenewswire.com - March 5 at 4:30 PMCandel Therapeutics Stock (NASDAQ:CADL), Short Interest Reportbenzinga.com - February 21 at 11:29 PMShort Interest in Candel Therapeutics, Inc. (NASDAQ:CADL) Declines By 10.9%marketbeat.com - February 15 at 11:31 AMCandel's Can-3110 Receives FDA Fast Track Designationmarkets.businessinsider.com - February 13 at 5:13 PMCandel Therapeutics: CAN-3110 Receives FDA Fast Track Designation for Treatment of Recurrent High-Grade Gliomafinanznachrichten.de - February 13 at 9:54 AMCandel Therapeutics Sets Stage For Success With Cancer-Fighting Immunotherapiesbenzinga.com - February 13 at 9:54 AMKrystal Biotech, Candel, Edgewise gain after FDA fast track tagsmsn.com - February 13 at 9:54 AMCAN-3110 Receives FDA Fast Track Designation for Treatment of Recurrent High-Grade Gliomafinance.yahoo.com - February 13 at 9:54 AMCandel Therapeutics Sets Path to Success: Recent Achievements Pave the Way for a Promising 2024 Propelled by Key Value Drivers and Catalystsfinance.yahoo.com - February 5 at 10:46 AMCandel (CADL) Rises on FDA's Fast Track Status for CAN-2409finance.yahoo.com - December 13 at 2:06 PMCandel Therapeutics Shares Soar After FDA Fast Track of CAN-2409marketwatch.com - December 13 at 12:47 AMCandel Receives FDA Fast Track Designation For CAN-2409 Plus Prodrugmarkets.businessinsider.com - December 12 at 9:44 AMCandel Therapeutics Receives FDA Fast Track Designation for CAN-2409 in Pancreatic Cancerfinance.yahoo.com - December 12 at 9:44 AMCandel downsizes to focus on oncolytic virus-based cancer therapiesmsn.com - November 29 at 7:49 PMImmuno-oncology firm Candel cuts its workforce in halfbizjournals.com - November 28 at 7:05 PMCandel Therapeutics to Cut Workforce in Halfmarketwatch.com - November 28 at 2:05 PMCandel to cut 50% of staff in portfolio reorganizationmsn.com - November 28 at 2:05 PMCandel Therapeutics Announces Restructuring to Prioritize Resources on Key Value Drivers for Expanded Development of CAN-3110, the enLIGHTEN™ Discovery Platform, and Key Clinical Readouts for CAN-2409finance.yahoo.com - November 28 at 2:05 PMmarketbeat.com - November 28 at 9:10 AMCandel Therapeutics Inc CADLmorningstar.com - November 23 at 6:29 PMCandel Therapeutics GAAP EPS of -$0.29seekingalpha.com - November 11 at 7:53 PM Get Candel Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CADL and its competitors with MarketBeat's FREE daily newsletter. Email Address SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. CADL Media Mentions By Week CADL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CADL News Sentiment▼0.970.48▲Average Medical News Sentiment CADL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CADL Articles This Week▼01▲CADL Articles Average Week Get Candel Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CADL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CGEN News Today LENZ News Today INMB News Today GNFT News Today GRPH News Today VXRT News Today PSTX News Today IPSC News Today MOLN News Today KOD News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CADL) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Candel Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
